CURRICULUM VITAE Name : VAN...

CURRICULUM VITAE

Name : VAN VLIERBERGHE

First name : Hans

Born : Gent, 15 October 1964

Degrees

- Laureate van de Wetenschappelijke A afdeling 1982

Sint-Amandusinstituut, Sint-Michielsstraat 2, 9000 Gent

- Medical Doctor (MD) with the greatest dinstinction

R.U.G. July 1989

- PhD (April 2002): The haptotglobin polymorphism in hereditary haemochromatosis

and chronic hepatitis C.

- Legal degree of consultant in internal medicine 01 oktober 1994.

- Legal degree of consultant in gastroenterology 17-07-1997.

- Since 1 oktober 1995 : Staff member of the department of gastroenterology, Ghent

University Hospital. Special activities: hepatology and liver transplantation.

- Since October 1st, 2003: Associate Professor in Gastroenterology and Hepatology

Publications

H. Van Vlierberghe, M. De Vos, G. De Cock, C. Cuvelier, A. Elewaut.

Fundic gland polyps; three other case reports suggesting a possible association with acid

suppressing therapy.

Acta Gastroenterol Belg 1997; 60: 240-242.

D. Elewaut, N. Van Damme, F. de Keyser, D. Baeten, P. De Paepe, H. Van Vlierberghe, H.

Mielants, C. Cuvelier, G. Verbruggen, E.M. Veys, M. De Vos.

Altered expression of alfaEbeta7 integrin on intra-epithelial and lamina propria

lymphocytes in patients with Crohn's disease.

Acta Gastroenterologica Belgica 1998; 61: 288-294.

H. Van Vlierberghe, P. Duyck, P. Bernard, C. Braxel, J. Versieck (†), A. Elewaut.

Multifocal fatty infiltration of the liver; an aspecific presentation form of hepatitis C

infection.

Acta Gastro-enterologica Belgica 1998; 61: 379-381.

H. Van Vlierberghe, K.J. Mortelé.

Mediastinal mass in a patient with cirrhosis.

Journal of Hepatology 1998; 29: 1004.

M.L. Hautekeete, I. Colle, H. Van Vlierberghe, A. Elewaut.

Symptomatic liver injury probably related to sertraline.

Gastroenterologie Clinique Biologique 1998; 22: 364-365.

Bekkering FC, Brouwer JT, Leroux-Roels G, Van Vlierberghe H, Elewaut A, Schalm SW.

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to

standard therapy.

Journal of Hepatology 1998; 28: 960-964.

H. Van Vlierberghe, M. De Vos, M. Hautekeete, A. Elewaut.

Severe complications following endoscopic variceal ligation: should EVL be avoided in Child

C patients?


S. Depraetere, E. Van Kerschaever, H. Van Vlierberghe, A. Elewaut, J. Brouwer, H.

Niesters, S. Schalm, G. Maertens, G. Leroux-Roels.

Long term response to interferon treatment in chronic hepatitis C patients is associated

with a significant reduction in anti-E1 envelope antibody titers.

Journal of Medical Virology 2000; 60: 126-132.

K.J.Mortelé, M.Praet, H.Van Vlierberghe, M.Kunnen, P.R.Ros. CT and MR imaging findings

in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. American Journal

of Radiology 175, September 2000: 687-692.

V.Meersschaut, K.J.Mortelé, R.Troisi, H.Van Vlierberghe, M.De Vos, L.Defreyne, B.de

Hemptinne, M.Kunnen. Value of MR cholangiography in the evaluation of postoperative

biliary complications following orthotopic liver transplantation. European Radiology 2000,

10: 1576-1581.

H. Van Vlierberghe, L. Messiaen, M. Hautekeete, A. De Paepe.

Prevalence of the Cys282Tyr and His63Asp mutation in Flemish patients with hereditary

hemochromatosis.


Dixon J, Delwaide J, Horsmans Y, Van Vlierberghe H. Chronic hepatitis B therapy with

lamivudine in clinical practice. Summary of the discussion. Acta Gastro-enterologica

Belgica; 63(4): 357-358, 2000.

I.Colle, H.Van Vlierberghe, R.Troisi, B.de Hemptinne, M.De Vos. Living related adult-to-

adult liver transplantation: which patient should benefit from this technique? Acta Gastro-

enterologica Belgica 2001, 64: 1-3.

H. Van Vlierberghe, M.Dhont, H.Verdievel, M.De Vos, A.Elewaut. Influence of the intake of

low oral contraceptives, alcohol and grapefruit in the results of the C13 aminopyrin breath

test. Digestive Diseases and Sciences, 46(1), 133-139, January 2001.

R.Troisi, I.Colle, H.Van Vlierberghe, U.J.Hesse, O.Cuomo, B.de Hemptinne. Splenectomy

and liver transplantation. Transplant Proceedings, vol 33, No 1-2, 2001.

H.Van Vlierberghe, J.R.Delanghe, M.De Vos, G.Leroux-Roels and the BASL. Factors

influencing ribavirin induced anemia. Journal of Hepatology, 34(6), 911-916, 2001.

Mortele KJ, De Keukeleire K, Praet M, Van Vlierberghe H, de Hemptinne B, Ros PR.

Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-

enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur

Radiol 2001; 11(9): 1631-8.

H. Van Vlierberghe, J.R. Delanghe, S.De Bie, M. Praet, A. De Paepe, L. Messiaen,

M. De Vos, G. Leroux-Roels.

Association between Cys282Tyr missense mutation and haptoglobine phenotype

polymorphism in patients with chronic hepatitis C.

European Journal of Gastroenterology and Hepatology 2001, 13: 1077-1081.

B.Brans, F. De Winter, L.Defreyne, R.Troisi, P.Vanlangenhove, H.Van Vlierberghe,

B.Lambert, M.Praet, B.de Hemptinne, RA Dierckx. The anti-tumoral activity of neoadjuvant

intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Cancer

Biother Radiopharm 2001; 16(4): 333-338.

S.De Coninck, H.Van Vlierberghe, M.De Vos, A.Elewaut. Review: hepatopulmonary

syndrome and portopulmonary hypertension. Acta Gastroenterol Belg 2001; 64(3): 286-

294.

H.Van Vlierberghe, M.Langlois, J.Delanghe, Y. Horsmans, P.Michielsen,

J.Henrion, R. Cartuyvels, J.Billiet, M.De Vos, G.Leroux-Roels. Haptoglobin

phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. Journal

of Hepatology 2001; 35(6): 707-711.

R.Schoonjans, B.Van Vlem, W.Vandamme, H.Van Vlierberghe, N.Van Heddeghem, W.Van

Biesen, A.Mast, R.Vanholder, N.Lameire, M.De Vos. Gastric emptying of solids in cirrhotic

and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterol

Hepatol 2002; 14(4): 395-398.

B.Brans, K.Van Laere, F.Gemmel, L.Defreyne, P.Vanlangenhove, R.Troisi, H.Van

Vlierberghe, I.Colle, B.de Hemptinne, R.A.Dierckx. Combining iodine-131-lipiodol therapy

with low-dose cisplatin as radiosensitizer: preliminary results in hepatocellular

carcinoma. Eur J Nucl Med 2002; 29: 928-932.

M.Adler, P.Goubau, F.Nevens, H.Van Vlierberghe. Hepatitis C virus: the burden of the

disease. Acta Gastroenterol Belg 2002; 65(2): 83-86.

H.Van Vlierberghe, I.Colle, R.Troisi, B.de Hemptinne, M.De Vos. Liver

transplantation and mental retardation. Acta Gastroenterologica Belg 2002; 65(2): 131-

132.

K.J.Mortelé, H.Van Vlierberghe, W.Wiesner, P.R.Ros. Hepatic veno-occlusive disease: MRI

findings. Abdom Imaging 2002, 27(5): 523-526.

R.Troisi, G.Militerno, E.Hoste, J.Decruyenaere, K.Colpaert, K.Monsieurs, I.Colle, H.Van

Vlierberghe, B.de Hemptinne. Are reduced tacrolimus dosages needed in the early

postoperative period following living donor liver transplantation in adults?

Transplantation Proceedings 2002; 34(5): 1531.

H.Van Vlierberghe, H.Verdievel, I.Colle, J.Delanghe, D.Bernard, M.Praet,

G.Leroux-Roels, M.De Vos. Non-transferrin-bound iron (NTBI) in untreated and

ribavirin treated chronic hepatitis C patients. Alimentary Pharmacology and

Therapeutics 2002; 16: 1555-1562.

I.Colle, H.Van Vlierberghe, R.Troisi, K.De Ridder, D.Benoit, B.de Hemptinne, M.De Vos.

Campylobacter-associated Guillain-Barré syndrome after orthotopic liver transplantation

for hepatitis C cirrhosis: a case report. Hepatology Research 2002; 24:205-211.

B.Brans, B.Lambert, De Beule E, F.De Winter, S.Van Belle, H.Van Vlierberghe, B.de

Hemptinne, R.A.Dierckx. Quality of life assessment in radionuclide therapy: a feasibility

study of the EORTC QLQ-C30 questionnaire in palliative I-131-Lipiodol therapy. Eur J

Nucl Med Molec Imag 2002; 29(10):1374-1379.

KJ Mortelé, M.Praet, H.Van Vlierberghe, B.de Hemptinne, K.Zou, PR Ros. Focal nodular

hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced

MRI. Abdom Imaging 2002; 27(6): 700-707.

Lai CL, Rosmawati M, Lao J, Van Vlierberghe H, Anderson FH, Thomas N, DeHertogh D.

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with

chronic hepatitis C infection. Gastroenterology 2002; 123: 1831-1838.

I.Colle, H.Van Vlierberghe, R.Brenard, R.Troisi, B.de Hemptinne, B Navez, S.De Coninck,

M.De Vos. Biliary complications of large echinococcus granulosus cysts: report of 2 cases

and review of the literature. Acta Clinica Belgica, 2002; 57(6): 351-356.

P.Michielsen, R.Brenard, N.Bourgeois, C.de Galocsy, J.Delwaide, J.Henrion, Y.Horsmans,

F.Nevens, H.Reynaert, G.Robaeys, D.Sprengers, H.Van Vlierberghe. Hepatitis C:

screening, treatment and prevention. Pratical guidelines. Acta Gastroenterologica Belgica

2003; 66: 15-19.

R.Troisi, G.Cammu, G.Militerno, L.De Baerdemaeker, J.Decruyenaere, E.Hoste, P.Smeets,

I.Colle, H.Van Vlierberghe, M.Petrovic, D.Voet, E.Mortier, U.J.Hesse, B.de Hemptinne.

Modulation of portal graft inflow: a necessity in adult living-donor transplantation?

Annals of Surgery 2003; 237(3): 429-436.

I.Colle, H.Van Vlierberghe, P.Pattyn, R.Troisi, D.Vogelaers, B.de Hemptinne, M. De Vos.

Cholestasis as presenting symptom of portal cavernoma. Hepatology Research 2003; 25:

32-37.

H.Van Vlierberghe, J.Delanghe. Haptoglobin polymorphism and iron hemostasis. Clinical

Chemistry 2003; 49(4): 708-709.

I.Colle, H.Van Vlierberghe.

Diagnosis and therapeutic problems of primary sclerosing cholangitis.

Acta Gastroenterologica Belgica 2003; 66(2): 155-159.

S.Steyaert, P.Vanlandschoot, H.Van Vlierberghe, H.Diepolder, G.Leroux-Roels. Soluble

CD14 levels are increased and inversely correlated with the levels of hepatitis B surface

antigen in chronic hepatitis B patients. Journal of Medical Virology 2003; 71(2): 188-

194.

H.Van Vlierberghe. NASH/NAFLD management. Summary of the discussion. Acta

Gastroenterologica Belgica 2003; 66: 154.

H.Van Vlierberghe, G.Leroux-Roels, M.Adler , N.Bourgeois , F.Nevens, Y.Horsmans,

J.Brouwer, I.Colle, J.Delwaide, R.Brenard, B.Bastens, J.Henrion, R.A. de Vries, C.de

Galocsy, P.Michielsen, G.Robaeys, L.Bruckers. Daily induction combination treatment with

alpha 2b interferon and ribavirin or standard combination treatment in naive chronic

hepatitis C patients. A controlled multicenter randomised trial. Journal of Viral Hepatitis

2003; 10: 460-466.

F.Nevens, T.Roskams, H.Van Vlierberghe, Y.Horsmans, D.Sprengers, A.Elewaut, V.Desmet,

G.Leroux-Roels, E.Quinaux, E.Depla, S.Dincq, C.Vander Stichele, G.Maertens, F.Hulstaert.

Improvement in liver histology and serum ALT is associated with immune response to

envelope protein E1 therapeutic vaccination in 24 patients with chronic hepatitis C.

Hepatology 2003; 38: 1289-1296.

I.Colle, D.Schoors, H.Van Vlierberghe, G.Van Maele, M.De Vos, H.Reynaert. Influence of

posture on haemodynamics, sodium and hormonal homeostasis in cirrhotic patients with

and without ascites. Acta Gastroenterologica Belgica 2003; 66: 206-212.

F.Gemmel, M.Ravier, R.Troisi, H.Van Vlierberghe, B.Lambert, V.Renard, RA Dierckx.

Radionuclide detection of peritoneovenous shunt patency. Clin Nucl Med 2003; 28(12):

986-987.

H.Van Vlierberghe, R.Troisi, I.Colle, S.Ricciardi, M.Praet, B.de Hemptinne Hepatitis C

infection (HCV) related liver disease: patterns of recurrence and outcome in cadaveric and

living donor liver transplantation in adults. Transplantation 2004; 77(2): 210-214.

M.R.Langlois, M.L.De Buyzere, H.Van Vlierberghe, J.R.Delanghe. Haptoglobin

polymorphism and serum ferritin concentration in ageing subjects. Br J Haematol 2004;

124: 555-556.

H.Van Vlierberghe, I.Borbath, J.Delwaide, J.Henrion, P.Michielsen, C.Verslype and the BASL

steering committee. BASL guidelines for the surveillance, diagnosis and treatment of

hepatocellular carcinoma. Acta Gastroenterologica Belgica 2004; 67(1): 14-25.

T.Bosman, K.Vonck, P.Claeys, H.Van Vlierberghe, M.De Clercq, J. De Reuck, P.Boon.

Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam?

Seizure 2004; 13: 76-81.

I.Colle, A.S.De Vriese, H.Van Vlierberghe, N.H.Lameire, M.De Vos. Systemic and splanchnic

haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk

in cirrhotic patients. Liver International 2004; 24: 63-68.

N.Callewaert, H.Van Vlierberghe, A.Van Hecke, W.Laroy, J.Delanghe, R.Contreras.

Noninvasive diagnosis of liver cirrhosis using DNA-sequencer-based total serum protein

glycomics. Nature Medicine 2004; vol 10(Nr4): 429-434.

J.T.Brouwer, F.Nevens, F.C.Bekkerering, N.Bourgeois, H.Van Vlierberghe, C.J.Weegink,

V.Lefebvre, J.van Hattum, J.Henrion, J.Delwaide, B.E.Hansen, S.W.Schalm. Reduction of

relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in

300 patients. Journal of Hepatology 2004; 40: 689-695.

I.Colle, A.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. Vascular

hyporesponsiveness in the mesenteric artery of anesthetised rats with cirrhosis and portal

hypertension. European Journal of Gastroenterology and Hepatology 2004; 16 (2): 139-

145.

H.Van Vlierberghe, M.Langlois, J.Delanghe. Haptoglobin polymorphism and iron

homeostasis in health and in disease. Clinica Chimica Acta 2004; 345(1-2): 35-42.

J.Delwaide, N.Bourgeois, C.Gerard, D.De Maeght, F.Mokaddem, E.Wain, B.Bastens,

J.Fevery, M.Gehenot, O.Le Moine, J.P.Martinet, G.Robaeys, B.Servais, M.Van Gossum,

H.Van Vlierberghe and the BASL. Treatment of acute hepatitis C with interferon alpha 2b:

early initiation of treatment is the most effective predictive factor of sustained viral

response. Alimentary Pharmacology and Therapeutics 2004; 20(1): 15-22.

V.Docnkier, R.Troisi, M.Toungouz, I.Colle, H.Van Vlierberghe, C.Jacquy, P.Martiat,

P.Stordeur, L.Zhou, N.Boon, M.Lambermont, L.Schandené, J.L.Van Laethem, L.Noens,

M.Gelin, B.de Hemptinne, M.Goldman. Donor stem cell infusion after non-myeloablative

conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.

Transplant Immunology 2004; 13(2): 139-46.

I.Colle, H.Van Vlierberghe, R.Troisi, B.de Hemptinne. Transplanted liver: consequences of

denervation for liver functions. Anat Rec 2004; 280A (1): 924.

B.Lambert, K.Bacher, L.Defreyne, F.Gemmel, H.Van Vlierberghe, JM Jeong, RA Dierckx,

C.Van de Wiele, H.Thierens, F.De Vos. 188Re-HDD/Lipiodol therapy for hepatocellular

carcinoma: a phase I clinical trial. Journal of Nuclear Medicine 2005; 46: 60-66.

Lambert B, Praet M, Vanlangenhove P, Troisi R, Hemptinne B, Gemmel F, Van Vlierberghe

H, Van de Wiele C. Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients

awaiting liver transplantation: pathology of the explant livers and clinical outcome. Cancer

Biother Radiopharm. 2005 Apr; 20(2):209-14.

R.Troisi, S.Riccairdi, P.Smeets, M.Petrovic, G.Van Maele, I.Colle, H.Van Vlierberghe, B.de

Hemptinne. Effects of hemi-portocaval shunts for inflow modulation in the outcome of

small-for-size grafts in living donor liver transplantation. American Journal of

Transplantation. 2005; 5: 1397-1404.

T.Botelberge, H.Van Vlierberghe, D.Voet, L.Defreyne. Detachable balloon emobilzation of

an arterioportal fistula following liver biopsy in a liver transplant recipient: a case report

and review of the literature. Cardiovascular and Interventional Radiology 2005; 28: 1-5.

I.Desombere, H.Van Vlierberghe, S.Couvent, F.Clinckspoor, G.Leroux-Roels. Comparison of

qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative

(COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C

(HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV

infections. J. Clinical Microbiololgy 2005; 43(6):2590-2597.

E.Nagler, H.Van Vlierberghe, I.Colle, R.Troisi, B.de Hemptinne. Impact of MELD on short-

term and long-term outcome following liver transplantation: a European perspective. Eur J

Gastroenterol Hepatol. 2005 Aug; 17(8):849-56.

Hutse V, Verhaegen E, De Cock L, Quoilin S, Vandenberghe H, Horsmans Y, Michielsen P,

Van Damme P, Van Vlierberghe H, Claeys F, Vranckx R, Van Oyen H. Oral fluid as a

medium for the detection of hepatitis B surface antigen. J Med Virol. 2005 Jul 19;

77(1):53-56.

S.Ricciardi, D.Vogelaers, F.Van Wanzeele, I.Colle, H.Van Vlierberghe, B.de Hemptinne,

R.Troisi. Specific problems in a HIV positive patient with end-stage alcoholic liver disease

after liver transplantation: infections and immunosuppression. Transplantationsmedizin

2005; 17: 42-49.

Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck

J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C. (188)Re-HDD/lipiodol

therapy for hepatocellular carcinoma: an activity escalation study. Eur J Nucl Med Mol

Imaging. 2006; 33(3):344-352

Van Vlierberghe H, Colle I, Henrion J, Michielsen P, Delwaide J, Reynaert H, Borbath I,

Martinet JP, Sprengers D, Brenard R; Belgian Assocation for the Study of the Liver

steering committee. The HepCar registry: report on a one-year registration program of

hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC? Acta

Gastroenterol Belg. 2005 Oct-Dec; 68(4):403-11.

G.Robaeys, H.Van Vlierberghe, C.Matheï, M.Van Ranst, L.Bruckers, F.Buntinx on behalf of

the members of the BASL steering committee and the Benelux Study Group. Similar

compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug

use in comparison with other infection causes. Eur J Gastroenterol Hepatol 2006; 18(2):

159-166.

Anja M. Geerts, An S. De Vriese, Eline Vanheule, Hans Van Vlierberghe, Siska Mortier,

Kin-Jip Cheung, Pieter Demetter, Norbert Lameire, Martine De Vos, Isabelle

Colle.Increased angiogenesis and permeability in the mesenteric microvasculature of rats

with cirrhosis and portal hypertension: an in vivo study. Liver International; Volume 26,

Issue 7, 2006Sep1, Page 889-898.

Reynaert H, Van Vlierberghe H, De Beeck BO, Roskams T. Management of small focal

liver lesions in a cirrhotic liver: discussion. Acta Gastroenterol Belg. 2006 Apr-

Jun;69(2):236-7.

Donckier V, Troisi R, Le Moine A, Toungouz M, Ricciardi S, Colle I, Van Vlierberghe H,

Craciun L, Libin M, Praet M, Noens L, Stordeur P, Andrien M, Lambermont M, Gelin M,

Bourgeois N, Adler M, de Hemptinne B, Goldman M. Early immunosuppression withdrawal

after living donor liver transplantation and donor stem cell infusion. Liver Transpl. 2006

Sep 26; 12(10):1523-1528.

Anja M.Geerts, Kin-Jip Cheung, Hans Van Vlierberghe, An S. De Vriese, Siska Mortier, Eline

Vanheule, Norbert Lameire, Martine De Vos, Isabelle Colle. Decreased leukocyte

recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by

trreatment with peginterferon: an in vivo study. J Hepatol; 2007, 46(5):804-15.

Desombere I, Van Vlierberghe H, Weiland O, Hultgren C, Sallberg M, Quiroga J, Carreno V,

Leroux-Roels G. Serum levels of anti-NS4a and anti-NS5a predict treatment response of

patients with chronic hepatitis C. J Med Virol. 2007 Apr 24;79(6):701-713.

I.Colle, C.Van Steenkiste, A.Geerts, H.Van Vlierberghe. Hepatopulmonary syndrome and

portopulmonary hypertension: what’s news. Acta Gastroenterologica Belgica; Vol LXX, Apr-

June 2007, 203-209.

I.Colle, van Onna, F.Berrevoet, H.Van Vlierberghe, A.Geerts, R.Troisi, B.de Hemptinne.

One-sided limb lymphedema in a liver transplant recipient receiving Sirolimus. Acta

Gastroenterologica Belgica. Vol 70, Fasc. 2 of 3, 2007

Veldt BJ, van der Vliet HJ, von Blomberg BM, van Vlierberghe H, Gerken G, Nishi N,

Hayashi K, Scheper RJ, de Knegt RJ, van den Eertwegh AJ, Janssen HL, van Nieuwkerk CM.

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the

treatment of chronic hepatitis C.J Hepatol. 2007, 47(3): 356-65.

Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I, De Gendt S, de

Hemptinne B. The value of laparoscopic liver surgery for solid benign hepatic tumors.

Surg Endosc. 2007 Aug 21; [Epub ahead of print]

Dezza MC, Berrevoet F, Sainz-Barriga M, Rossetto A, Colenbie L, Haentjens I, Van

Vlierberghe H, Colle I, Van Huysse J, Praet M, Rogiers X, de Hemptinne B, Troisi R. The

choice of recipient does not have a bearing on early outcome in liver transplant patients

receiving grafts from non-heart-beating donors: a reappraisal? Transplant Proc. 2007

Oct;39(8):2675-7.

Craciun L, Stordeur P, Troisi R, Le Moine A, Toungouz M, Colle I, Van Vlierberghe H, Loi P,

Lucidi V, Praet M, de Hemptinne B, Goldman M, Donckier V.

A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver

transplant recipients with donor-specific hyporesponsiveness. Transplant Proc. 2007

Oct;39(8):2665-7.

H. Van Vlierberghe. The hepatitis C virus burden: a Dutch point of view. Netherlands

Journal of Medicine January 2008, Vol 66, No.1, p 1-2.

E.Vanheule, A.M.Geerts, H.Reynaert, H.Van Vlierberghe, A.Geerts, M.De Vos, I.Colle.

Influence of somatostatin and octreotide on liver microcirculation in an experimental

mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver

International 2008, 28(1): p.107-116.

K.J.Cheung, K.Tilleman, I.Colle, D.Deforce, H.Van Vlierberghe. Serum proteomics and

liver fibrosis. Eur J Gastroenterol Hepatol. 2008 May;20(5):450-64.

Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H. Hemodynamic Changes in

Splanchnic Blood Vessels in Portal Hypertension. Anat Rec (Hoboken). 2008 May 16;

291(6):699-713.

Geerts AM, Vanheule E, Van Vlierberghe H, Leybaert L, Van Steenkiste C, De Vos M, Colle

I. Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow

in portal hypertensive mice. Hepatol Res. 2008; 38: 1130-1139.

I.Colle, K.De Keukeleire, W.Pauwels, H.Van Vlierberghe. ‘Hepatic’ encephalopathy

because of spontaneous mesenterico-caval shunt. Liver International, 28(7) p 982, 2008.

A. Geerts, E. Vanheule, M. Praet, H. Van Vlierberghe, M. De Vos, I. Colle. Comparison of

three research models of portal hypertension in mice: macroscopic, histological and

portal pressure evaluation. Int J Exp Path 2008; 89: 251-263.

H. Van Vlierberghe.

Tetrahydrofuraanhepatitis.

Belgisch Tijdschrift voor Geneeskunde, volume 51, nr. 1, 70-72, 1995.

H. Van Vlierberghe, D. Voet, F. De Smet, M. De Vos, M. Afschrift, A. Elewaut.

Biliare Ascariasis.


H. Van Vlierberghe, M. De Vos.

Medicamenteuze behandeling van inflammatoir darmlijden.

Belgische Tijdschrift voor Geneeskunde, volume 52, nr. 11, 717-720, 1996.

H. Van Vlierberghe.

Terugkeer van reis met diarree.


H. Van Vlierberghe, L. Messiaen, M. Hautekeete, A. Elewaut, A. De Paepe.

Erfelijke hemochromatose: van Kelten en IJzeren Tijdperk tot genetische diagnose.


H. Van Vlierberghe.

Vragenbus: hemochromatose-hemosiderose.

Belgisch Tijdschrift voor Geneeskunde, volume 55 nr. 5, 385,1999.

H. Van Vlierberghe.

Brieven aan de redactie: Erfelijke hemochromatose: van Kelten en IJzeren Tijdperk tot

genetische diagnose.


N.M.Keereman, H.Van Vlierberghe. De behandeling van hepatitis C bij intraveneuze

druggebruikers: een stand van zaken. Belgisch Tijdschrift voor Geneeskunde, volume 58,

nr. 4, 240-244, 2002.

N.Stoens, H.Van Vlierberghe. Pyleflebitis: casuïstiek en literatuuroverzicht. Belgisch

Tijdschrift voor Geneeskunde, volume 58, nr 10, 700-704, 2002.

F.De Winter, B.Brans, B.Lambert, F.Gemmel, K.Van Laere, L.Defreyne, H.Van Vlierberghe,

B de Hemptinne, K.Bacher, R.A. Dierckx. Locoregionale 131 I – lipiodoltherapie bij de

behandeling van het hepatocellulair carcinoom. Belgisch Tijdschrift voor Geneeskunde,

volume 59, Nr 8, 532-541, 2003.

A.Geerts, I.Colle, H.Van Vlierberghe, M.De Vos. Een enterovaginale fistel secundair aan een

geperforeerd ontstoken divertikel van Meckel. Belgisch Tijdschrift voor Geneeskunde,

volume 59, Nr 8, 542-548, 2003.

H.Van Vlierberghe, M. Bogaert. Vitaminen en Mineralen: wetgeving en toxiciteit. Belgisch

Tijdschrift voor Geneeskunde, volume 59, nr 23, 1455-1459, 2003.

H.Van Vlierberghe.Boekbespreking: ‘Vitamins and minerals: health benefits and intake recommendations’.

Belgisch Tijdschrift voor Geneeskunde, volume 60, nr 2, 152, 2004.

I.Colle, L.Vandenbussche, H.Van Vlierberghe, R.Troisi, M.De Vos, B.de Hemptinne.

Voedingstoestand van levertransplantatiekandidaten.

Belgisch Tijdschrift voor Geneeskunde, volume 61, nr 10, 766-773, 2005.

C. Van Steenkiste, H. Van Vlierberghe, I. Colle. Een praktisch overzicht van hepatitis C. Tijdschrift voor geneeskunde 2007; 63: 140-151.

H.Van Vlierberghe, I.Colle, L.Colenbie, K.Vandewoude, R.Troisi, B.de Hemptinne. De MELD-score: naar een verbetering van de orgaanallocatie bij levertransplantatie. Tijdschrift voor geneeskunde 2007; 63(6): 251-255.

Abstracts

H. Van Vlierberghe, A.E. Elewaut, G. Leroux-Roels, A. Elewaut.

High-dose interferon alfa 2b retreatment in hepatitis C positive non 1b non-responders

results in a high percentage of sustained response.

Acta Gastro-enterologica Belgica, vol. 60, fasc.1, Ab C3, 1997.

H. Van Vlierberghe, R. Beke, B. de Hemptinne, A. Elewaut.

Significance of auto-antibodies appearing after liver transplantation.

Acta Gastro-enterologica Belgica, vol. 60, fasc.1, Ab C56, 1997.

H. Van Vlierberghe, A.E. Elewaut, G. Leroux-Roels, A. Elewaut.

High-dose interferon alfa 2b retreatment in hepatitis C positive non 1b non-responders

results in a high percentage of sustained response.

Journal of Hepatology, supl. 1, vol.26, Ab C01/63, 1997.

H. Van Vlierberghe, R. Beke, B. de Hemptinne, A. Elewaut.

Significance of auto-antibodies appearing after liver transplantation.

Journal of Hepatology, supl. 1, vol. 26, Ab C18/11, 1997.

S. Depraetere, E. Van Kerschaver, H. Van Vlierberghe, A. Elewaut, E. Depla, G. Maertens,

G. Leroux-Roels.

Antibodies to E1 and E2 in chronic HCV patients with a long-term response to interferon

therapy.

Hepatology, 1997 vol 26, no 4, supl Ab 717.

F.C. Bekkering, J.T. Brouwer, G. Leroux-Roels, H. Van Vlierberghe, A. Elewaut, SW Schalm.

Ultrarapid hepatitis C virus clearance by daily high dose interferon in non-responders to

standard therapy.

Hepatology 1997, vol 26, no 4, supl Ab 1147.

H. Van Vlierberghe, A.E. Elewaut, F.C. Bekkering, J.T. Brouwer, G. Leroux-Roels, S.W.

Schalm, A. Elewaut.

Early disappearance of HCV RNA is a prognostic marker of sustained response during

retreatment of hepatitis C non sustained responders.


H. Van Vlierberghe, H. Verdievel, M. Hautekeete, A. Elewaut.

Influence of an acute alcohol intake on the results of the C13 aminopyrine breath test.



Influence of ethinylestradiol on the results of the C13 aminopyrine breath test. Hepatology

1997, vol 26, no 4, supl Ab 1972.

H. Van Vlierberghe, L. Messiaen, M. Hautekeete, A. De Paepe, A. Elewaut.

Prevalence of the Cys282Tyr mutation in patients with chronic hepatitis C.

Acta Gastroenterol Belg, 1998, 61: A3.

H. Van Vlierberghe, L. Messiaen, J. Versieck (†), M. Hautekeete, A. De Paepe, A. Elewaut.

High prevalence of the HFE Cys282Tyr mutation in Belgian patients with genetic

haemochromatosis.

Acta Gastroenterol Belg, 1998, 61: C2.

S. Depraetere, E. Van Kerschaver, H. Van Vlierberghe, A. Elewaut, E. Depla, G. Maertens,

G. Leroux-Roels.

Antibodies to E1 and E2 in chronic HCV patients with a long term response to interferon

therapy.

Acta Gastroenterol Belg, 1998, 61: A19.


Influence of ethinylestradiol on the results of the C13 aminopyrine breath test.



Influence of an acute alcohol intake on the results of the C13 aminopyrine breath test.


S. De Laere, R. Troisi, F. Berrevoet, M. Hautekeete, H. Van Vlierberghe, U.J. Hesse, P.

Pattyn, B. de Hemptinne.

Liver resections for primary hepatocellular carcinoma.


R. Troisi, B. Jacobs, D. Van de putte, M. Hautekeete, H. Van Vlierberghe, M. Praet, L.

Defreyne, U.J. Hesse, P. Pattyn, B. de Hemptinne.

Resection of metastatic colorectal liver cancer: preliminary results of a single center

experience.


F. Berrevoet, J. Dossche, U. Hesse, H. Van Vlierberghe, M. Praet, P. Pattyn, B. de

Hemptinne.

Alcoholic liver cirrhosis as an indication for liver transplantation: a long term evaluation.

Acta Gastro-enterologica Belgica, 1999, 62(1): D12.

F. Berrevoet, D. Van Den Putte, L. Defreyne, H. Van Vlierberghe, U. Hesse, P. Pattyn, B. de

Hemptinne.

Is there still an indication for surgical shunts in the treatment of end-stage liver cirrhosis?


H. Van Vlierberghe, F. Van Durme, H. Verdievel, A. Elewaut.

Impaired liver function disturbs C13 glycine breath test interpretation.


B. Callens, E. Robberecht, P. Verloo, H. Van Vlierberghe.

Examination of the hepatic Microsomal function in cystic fibrosis by the C13 aminopyrin

breath test.


K.J. Mortelé, M. Praet, H. Van Vlierberghe, B. de Hemptinne, M. Kunnen.

Usual and unusual cystic focal liver lesions: CT and MR imaging with pathological

correlation.

Acta Gastro-enterologica Belgica, 1999, 62(1): F3.

H. Van Vlierberghe, J.R. Delanghe, L. Messiaen, G. Leroux-Roels, M. Praet, A. De Paepe, A.

Elewaut, M. De Vos.

Interaction between the Cys282Tyr missense mutation and the haptoglobin phenotype


Hepatology 1999, vol 30, nr. 4, Pt2, Ab 1741.

H. Van Vlierberghe, G. Leroux-Roels, N. Bourgeois, F. Nevens, I. Colle, J. Henrion, J.

Delwaide, Y. Horsmans, R. Brenard, P. Michielsen, G. Robaeys.

Daily induction treatment with alfa 2b interferon in naive chronic hepatitis C patients

results in a higher early response. A controlled multicenter randomized trial.

Hepatology 1999, vol 30, nr. 4, Pt 2, Ab 1884.

H. Van Vlierberghe, J.R. Delanghe, L. Messiaen, M. Praet, A. De Paepe, M. De Vos, G.

Leroux-Roels.

Interaction between the Cys282Tyr missense mutation and the haptoglobin phenotype


Acta Gastro-enterologica Belgica 2000, vol 63, Fasc1, A8.

H. Van Vlierberghe, J.R. Delanghe, M. De Vos, G. Leroux-Roels and the BASL steering

committee.

Ribavirin induced hemolysis is haptoglobin phenotype dependent.

Acta Gastro-enterologica Belgica 2000, vol 63, Fasc 1, A9.

H. Van Vlierberghe, G. Leroux-Roels, N. Bourgeois, F. Nevens, I. Colle, J. Henrion, J.

Delwaide, Y. Horsmans, R. Brenard, P. Michielsen, G. Robaeys, L. Bruckers.

Daily induction treatment with alfa 2b interferon in naive chronic hepatitis C patients

results in a higher early response.

Acta Gastro-enterologica Belgica 2000, vol 63, Fasc 1, A11.

H.Van Vlierberghe, G.Leroux-Roels, N.Bourgeois, F.Nevens, I.Colle, J.Henrion, J.Delwaide,

Y.Horsmans, R.Brenard, P.Michielsen, G.Robaeys, L.Bruckers. Daily induction combination

treatment with alfa2b interferon or standard combination treatment in naive chronic

hepatitis C patients. A controlled multicenter randomized trial. Hepatology 2000; 32, Ab

819.

J.Lerut, F.Roggen, B.de Hemptinne, H.Van Vlierberghe, L.Colenbie, J.Pirenne, F.Nevens,

D.Van Hees, O.Detry, J.Delwaide, M.F.Hans, M.Adler, M.Gelin, I.Sénépart, M.Joris. One

year experience of the Belgian liver intestine committee (BLIC) intranet database. Acta

Gastro-enterologica Belgica 2001, vol 64, Fasc 1, A7.

J.Delwaide, N.Bourgeois, C.Gérard, F.Mokaddem, E.Wain, B.Bastens, J.Fevery, M.Gehenot,

O.Lemoine, J.P.Martinet, G.Robaeys, B.Servais, A.Van Gossum, H.Van Vlierberghe and the

BASL. Treatment of acute hepatitis C with interferon alfa-2 prevents chronicity. A Belgian

multicenter study. Acta Gastro-enterologica Belgica 2001, vol 64, Fasc 1, A13.

H.Van Vlierberghe, G.Leroux-Roels, N.Bourgeois, F.Nevens, I.Colle, J.Henrion, J.Delwaide,

Y.Horsmans, R.Brenard, P.Michielsen, G.Robaeys, L.Bruckers. Daily induction combination

treatment with alfa 2b interferon or standard combination treatment in naive chronic

hepatitis C patients. A controlled multicenter randomised trial. Acta Gastro-enterologica

Belgica 2001, vol 64, Fasc 1, D21.

R.Troisi, I.Colle, B.Brans, H.Van Vlierberghe, F.Dewinter, P.Vanlangenhove, L.Defreyne,

R.Dierckx, B. De Hemptinne, M.Praet. A pilot study combining neo-adjuvant intra-arterial

131 iodine-labeled lipiodol and liver transplantation as multimodality treatment for

hepatocellular carcinoma: preliminary results. Acta Gastro-enterologica Belgica 2001, vol

64, Fasc 1, D52.

C.Lai, M.Rosmawati, J.Lao, H.Van Vlierberghe, F.Anderson, N.Thomas, D.De Hertogh. A

phase II study of Entecavir versus Lamivudine in adults with chronic hepatitis B. Journal of

Hepatology, 2001, vol 34, suppl 1, abstract 1586.

M.Langlois, H.Van Vlierberghe, J.Billiet, R.Cartuyvels, P.Michielsen, Y.Horsmans,

J.Delanghe. Haptoglobin polymorphism: a modifier gene in hereditary hemochromatosis?

Clin Chem Lab Med 2001; 39 Suppl, pag S402.

Troisi R, Smeets P, Colle I, Van Zieleghem B, Van Vlierberghe H, Mortelé K, Ragozzino A,

Coumo O, de Hemptinne B. Donor evaluation for adult living donor liver transplantation:

characteristics, anatomical features and pitfalls. ESOT 2001, Lisabon, Portugal, 6-11

oktober 2001. Abstract 252.

Troisi R, Van Vlierberghe H, Colle I, Cuomo O, de Hemptinne B. Adult living donor liver

transplantation: a way to overcome donor shortage in Western countries? ESOT 2001,

Lissabon, Portugal, 6-11 oktober 2001. Abstract 510.

H.Van Vlierberghe, M.Langlois, J.Delanghe, Y.Horsmans, P.Michielsen, J.Henrion,

R.Cartuyvels, J.Billiet, M.De Vos, G.Leroux-Roels. Haptoglobin phenotype 2-2

overrepresentation in Cys282Tyr hemochromatotic patients. Gut, 49 (Suppl III), November

2001, Abstract nummer 1719.

H.Van Vlierberghe, H.Verdievel, I.Colle, M.De Vos. Non-transferrin-bound iron (NTBI) in

patients with chronic hepatitis C. Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab A1,

2001.

H.Van Vlierberghe, M.De Vos, N.Van Damme, A.Janssens, J.Delanghe, G.Leroux-Roels.

Down regulation of the CD163 monocyte-macrophage receptor in hereditary

hemochromatosis. Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab A2, 2001.


R.Cartuyvels, J.Billiet, M.De Vos, G.Leroux-Roels. Haptoglobin phenotype 2-2

overrepresentation in Cys282Tyr hemochromatotic patients. Acta Gastroenterologica

Belgica vol 64, Fasc 4, Ab A3, 2001.



and without ascites. Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab A4, 2001.

R.Troisi, H.Van Vlierberghe, I.Colle, G.Militerno, P.Smeets, J.Decruyenaere, E.Hoste,

S.Ricciardi, B.de Hemptinne. Living donor liver transplantation in adults: a single centre

experience. Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab A9, 2001.

U.J.Hesse, D.Meester, R.Troisi, B.de Hemptinne, P.Pattyn, H.Van Vlierberghe, M.De Vos,

N.Lameire, C.Cuvelier. Histologic findings in small bowel tissue following pancreatico-

duodenal allo-transplantation with venous drainage into the portal or systemic circulation.

Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab D11, 2001.

B.de Hemptinne, R.Troisi, J.Decruyenaere, E.Hoste, M.Praet, B.Brans, L.Defreyne, P.Pattyn,

U.Hesse, I.Colle, H.Van Vlierberghe. Liver transplantation for hepatocellular carcinoma.

Acta Gastroenterologica Belgica vol 64, Fasc 4, Ab I8, 2001.

Abdel-Hadi M, Praet M, Van Vlierberghe H, Hesse U, Troisi R, Matthijs B, El-Taweel G, de

Hemptinne B. Liver cell dysplasia and hepatocellular carcinoma: value of E-cadherin

staining. Laboratory Investigation; 82 (1) 1167, Jan 2002.

Abdel-Hadi M, Praet M, Van Vlierberghe H, Hesse U, Troisi R, Matthijs B, El-Taweel G, de

Hemptinne B. Liver cell dysplasia and hepatocellular carcinoma: value of E-cadherin

staining. Modern Pathology 15: (1) 1167, Jan 2002.



and without ascites. J Hepatol, vol 36, Suppl 1, Ab 155, 2002.


R.Cartuyvels, J.Billiet, M.De Vos, G.Leroux-Roels. Elevated serum iron indices in

haptoglobin phenotype 2-2 individuals being homozygous for the HFE missense mutation. J

Hepatol, vol 36, Suppl 1, Ab 583, 2002.

F.Hulstaert, F.Nevens, H.Van Vlierberghe, Y.Horsmans, D.Sprengers, A.Elewaut,

T.Roskams, E.Quinaux, S.Dincq, C.Vander Stichele, G.Maertens. Clinical development of

hepatitis C virus E1-based therapeutic vaccine: first results in patients. 9th International

Meeting on HCV and related viruses. 11th July 2002, San Diego

H.Van Vlierberghe, H.Verdievel, I.Colle, J.Delanghe, G.Leroux-Roels, M.De Vos. Non-

transferrin-bound iron in chronic hepatitis C. Gastroenterology, vol 122, N° 4, Ab M1468,

2002.

I.Colle, D.Schoors, H.Van Vlierberghe, M.De Vos, H.Reynaert. Haemodynamic, sodium and

hormonal homeostasis in cirrhotic patients with and without ascites and prolonged posture

change. Gastroenterology, vol 122, N° 4, Ab M1269, 2002.

R.Schoonjans, B.Van Vlem, N.Van Heddeghem, H.Van Vlierberghe, C.Van de Wiele,

N.Lameire, M. De Vos. A comparative study of the C13-octanoic acid breath test and Tc-99

scintigraphy for measuring solid gastric emptying in cirrhotic patients. Gastroenterology,

vol 122, N° 4, Ab W1066, 2002.

I.Colle, A.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. Systemic and splanchnic

hemodynamic effects of sildenafil in rats with cirrhosis and portal hypertension.

Hepatology, vol 36, N° 4, Ab 1388, 2002.

I.Colle, A.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. In vivo vascular

hyporeactivity in the mesenteric artery of rats with cirrhosis and portal hypertension.

Hepatology, vol 36, N° 4, Ab 2231, 2002.

I.Colle, A.S.De Vriese, H.Van Vlierberghe, N.H.Lameire, M.De Vos. In vivo vascular

hyporeactivity in the mesenteric artery of rats with cirrhosis and portal hypertension. Acta

Gastroenterologica Belgica; 2003, 66: Abstract A05.

G.Robaeys, H.Van Vlierberghe, F.Nevens, C.Mathei, M.Van Ranst, L.Bruckers, F.Buntinx

and the BASL. Influence of age on response to treatment with interferon alfa 2b and

ribavirin in chronic hepatitis C patients infected with genotype 2/3 virus. Acta


G.Robaeys, H.Van Vlierberghe, M.Van Ranst, C.Mathei, L.Bruckers, F.Buninx and the BASL.

Compliance and effect of treatment for chronic hepatitis C in intravenous drug users. Acta


R.Troisi, H.Dick, G.De Cuypere, S.Ricciardi, D.Vogelaers, I.Colle, H.Van Vlierberghe,

G.Militerno, U.J.Hesse, B.de Hemptinne. Psychological issues after donation: a

retrospective donor survey following living donor liver transplantation in adult. Acta

Gastroenterologica Belgica; 2003, 66: Abstract D03.

H.Van Vlierberghe, R.Troisi, I.Colle, S.Ricciardi, M.Praet, U.J.Hesse, B.de Hemptinne.

Hepatitis C infection does not worsen general outcome in adult living liver transplantation.

Acta Gastroenterologica Belgica; 2003, 66: Abstract D06.

Y.Horsmans, I.Colle, H.Van Vlierberghe, P.Langlet, M.Adler, R.Brenard, P.Michielsen,

N.Bourgeois, V.Lefèbvre, J.Henrion, X.De Koninck, L.Bruckers and the BASL. Study in

chronic hepatitis C patients comparing three different combination therapies with interferon

alpha 2b and ribavirin: weekly peg-interferon alpha 2b versus daily interferon alpha 2b

versus standard regimen of interferon alpha 2b. Acta Gastroenterologica Belgica; 2003, 66:

Abstract D18.

R.Troisi, S.Ricciardi, I.Colle, H.Van Vlierberghe, J.Decruyenaere, E.Hoste, P.Smeets,

D.Vogelaers, M.Praet, G.Militerno, U.J.Hesse, B.de Hemptinne. Indications, pittfals and

general outcome in living donor liver transplantation in adults. Acta Gastroenterologica

Belgica; 2003, 66: Abstract D20.

I.Colle, A.S.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. Systemic and splanchnic

hemodynamic effects of sildenafil in rats with cirrhosis and portal hypertension. Acta

Gastroenterologica Belgica; 2003, 66: Abstract D46.

M.Praet, P.Demetter, L.Ferdinande, T.Botelberghe, H.Van Vlierberghe, I.Colle, R.Troisi, B.

De Hemptinne. Cholangiocarcinoma: predictive values of clinicopathological features. Acta

Gastroenterologica Belgica; 2003, 66: Abstract P01.

M.Praet, L.Defreyne, P.Vanlangenhove, A.Janssens, H.Van Vlierberghe, B.de Hemptinne.

Percutaneous transhepatic bile tract cytology. Acta Gastroenterologica Belgica; 2003, 66:

Abstract P12.

I.Colle, A.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos.

Systemic and splanchnic hemodynamic effects of sildenafil in rats with cirrhosis and portal

hypertension.

DDW meeting, Orlando, 2003.

R.Troisi, S.Ricciardi, P.Smeets, M.Petrovic, H.Van Vlierberghe, I.Colle, D.Voet, N.Herregods,

G.Militerno, M.Bilgiari-Foroutan, U.Hesse, V.Donckier, B.de Hemptinne. Adult living donor

liver transplantation in UNOS 2A and 2B patients with small-for-size grafts and graft inflow

modulation using a permanent hemiportocaval shunt. American Journal of Transplantation,

suppl 5, vol 3, 2003, Ab 200 (oral presentation) on the AST congres Washington 2003.

V.Donckier, R.Troisi, I.Colle, H.Van Vlierberghe, M.Toungouz, W.Burny, D.De Groote,

P.Martiat, M.Gelin, B.de Hemptinne, M.Goldman. Donor specific hyporensponsiveness and

immunosuppression withdrawal after living related HLA-mismatched liver transplantation

preceded by hematopoietic stem cell allograft. American Journal of Transplantation, suppl

5, vol 3, 2003, Ab 876 (poster presentation) on the AST congres Washington 2003.

H.Van Vlierberghe, R.Troisi, S.Ricciardi, I.Colle, M.Praet, P.Conoscitore, UJ Hesse, B.de

Hemptinne. Hepatitis C recurrence does not worsen general outcome in adult living donor

liver transplantation. American Journal of Transplantation, suppl 5, vol 3, 2003, Ab 1435

(poster presentation) on the AST congres Washington 2003.

F.Nevens, T.Toskams, H.Van Vlierberghe, Y.Horsmans, D.Sprengers, A.Elewaut, V.Desmet,

G.Leroux-Roels, E.Quinaux, E.Depla, S.Dincq, C.Vander Stichele, F.Hulstaert, G.Maertens.

Antifibrotic activity correlates with immune response to E1 therapeutic vaccination in 24

patients with chronic active hepatitis C. Journal of Hepatology, vol 38, suppl 2, 2003, Ab 47

(oral presentation) on the EASL congres in Geneva (3-6 juli 2003).

G.Robaeys, H.Van Vlierberghe, C.Mathei, M.Van Ranst, L.Bruckers, F.Buntinx. Compliance

and effect of treatment for chronic hepatitis C in intravenous drug users. Journal of

Hepatology, vol 38, suppl 2, 2003, Ab 569 (poster presentation) on the EASL congres in

Geneva (3-6 juli 2003).

H.Van Vlierberghe, R.Troisi, I.Colle, S.Ricciardi, M.Praet, P.Cononscitore, B.de Hemptinne.

Hepatitis C recurrence does not worsen general outcome in adult living donor liver

transplantation. (poster presentation) ESOT and ETCO congress, Venice Italy, September

2003.

R.Troisi, S.Ricciardi, P.Smeets, M.Petrovic, H.Van Vlierberghe, I.Colle, D.Voet, N.Herregods,

G.Militerno, UJ Hesse, B. De Hemptinnen. Clinical relevance of graft inflow modulation

using a permanent hemiportocaval shunt in UNOS status 2 adult patients undergoing living

donor liver transplantation with small for size grafts. (oral presentation). ESOT and ETCO

congress, Venice Italy, September 2003.

R.Troisi, S.Ricciardi, I.Colle, H.Van Vlierberghe, J.Decruyenaere, E.Hoste, P.Smeets,

L.Delrue, D.Vogelaers, M.Praet, G.Militerno, B.de Hemptinne. Living donor liver

transplantation in adults: indications, surgical techniques and overall results. (poster

presentation) ESOT and ETCO congress, Venice Italy, September 2003.

A.Geerts, I.Colle, A.De Vriese, S.Mortier, H.Van Vlierberghe, N.Lameire, M.De Vos.

Leukocyte recruitment is impaired in the peritoneal microcirculation of rats with portal

hypertension. Gut 2003; supplement II, vol 35, Abstract OP-G-261.


Peritoneal microvascular hyperpermeability and proliferation in rats with cirrhosis and

portal hypertension. Acta Clinica Belgica Vol 58; Nr 5, Abstract 5, 2003. (oral

presentation).


Decreased leukocyte recruitment in the peritoneal microcirculation of rats with portal

hypertension: in vivo microscopy. Clinica Belgica Vol 58; Nr 5, Abstract 13, 2003.(poster

presentation).

I.Colle, A.Geerts, A. De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. In vivo vascular

hyporeactivity in the mesenteric artery of rats with cirrhosis. Belgian Week of

Gastroenterology, Brugge, 12 februari 2004 (oral presentation).


Leukocyte recruitment is impaired in the peritoneal microcirculation of rats with portal

hypertension and cirrhosis. Belgian Week of Gastroenterology, Brugge, 12 februari 2004

(oral presentation).

N.Callewaert, H.Van Vlierberghe, A.Van Hecke, W.Laroy, J.Delanghe, R.Contreras.

Noninvasive diagnosis of liver cirrhosis using DNA-sequencer-based total serum protein

glycomics. Belgian Week of Gastroenterology, Brugge, 12 februari 2004 (oral

presentation).


Increased angiogenesis and permeability in the peritoneal microcirculation of rats with

cirrhosis and portal hypertension. Belgian Week of Gastroenterology, Brugge, 12

februari 2004 (oral presentation).

L.Lasser, P.Langlet, J.Mulkay, M.Adler, I.Colle, H.Van Vlierberghe, N.Boon, H.Louis, EM

Talib, C.de Galocsy, A.Reeckmans. Belgian multicenter randomised trial: interim analysis

of comparison of one year peginterferon alfa 2b ( Pegintron®) plus ribavirin (Rebetol®)

versus no treatment in patients with chronic hepatitis C and persistently normal ALT

levels. Belgian Week of Gastroenterology, Brugge, 12 februari 2004 (oral presentation).

H.Van Vlierberghe, I.Borbath, N.Bourgeois, J.Henrion and the BASL steering committee. The HepCar registry: report on a one-year registration program of hepatocellular carcinoma in Belgium. Belgian Week of Gastroenterology, Brugge, 12 February 2004 (oral presentation).

E.Nagler, H.Van Vlierberghe, R.Troisi, I.Colle, M.De Vos, B.de Hemptinne. Higher MELD scores pre liver transplantation have no influence on the long term survival of the liver transplant patient. Belgian Week of Gastroenterology, Brugge, 12 February 2004 (abstract).

I.Colle, H.Van Vlierberghe, L.Vandenbussche, R.Troisi, M.De Vos, B.de Hemptinne. Nutritional status in liver transplant candidates. Belgian Week of Gastroenterology, Brugge, 12 februari 2004 (abstract).

H.Van Vlierberghe, R.Troisi, I.Colle, M.Praet, B.de Hemptinne. Cadaveric or living related liver transplantation for hepatocellular carcinoma: is extension of the Milan criteria deleterious for tumour free survival? Belgian Week of Gastroenterology, Brugge, 12 februari 2004 (oral presentation).

Y.Horsmans, I.Colle, H.Van Vlierberghe, P.Langlet, M.Adler, R.Brenard, P.Michielsen, N.Bourgeois, V.Lefebvre, J.Henrion, X. De Koninck, L.Bruckers. Study in naive chronic hepatitis C patients comparing three different combination therapies with interferon alfa 2b and ribavirin: weekly PEG-interferon versus daily interferon versus standard regimen of interferon. Belgian Week of Gastroenterology, Brugge, 12 februari 2004 (oral presentation).

E.Nagler, H.Van Vlierberghe, R.Troisi, I.Colle, M.De Vos, B.de Hemptinne. Higher MELD scores pre liver transplantation have no influence on the long term survival of the liver transplant patient. Belgian Transplantation Society, Brussels, 11 maart 2004 (poster presentation).

H.Van Vlierberghe, R.Troisi, I.Colle, M.Praet, B.de Hemptinne. Cadaveric or living related liver transplantation for hepatocellular carcinoma: is extension of the Milan criteria deleterious for tumour free survival? Belgian Transplantation Society, Brussels, 11 maart 2004 (poster presentation).

A.Geerts, I.Colle, A.De Vriese, S.Mortier, H.Van Vlierberghe, N.Lameire, M.De Vos. Increased angiogenesis and permeability in the peritoneal circulation of rats with portal hypertension and cirrhosis. EASL congress, Berlin 2004. Abstract 33, Journal of Hepatology, vol 40(suppl1) (oral presentation).

E.Nagler, H.Van Vlierberghe, R.Troisi, I.Colle, M.De Vos, B.de Hemptinne. Higher MELD scores pre liver transplantation have no influence of the long term survival of the liver transplant patient. EASL congress, Berlin 2004. Abstract 173, Journal of Hepatology, vol 40(suppl1) (poster presentation).

A.Geerts, I.Colle, A.De Vriese, S.Mortier, H.Van Vlierberghe, N.Lameire, M.De Vos. Decreased leukocyte recruitment in the peritoneal microcirculation of rats with portal hypertension: role of L-selectin? EASL congress, Berlin 2004. Abstract 183, Journal of Hepatology, vol 40(suppl1) (poster presentation).

N.Callewaert, H.Van Vlierberghe, A.Van Hecke, W.Laroy, J.Delanghe, R.Contreras. Noninvasive diagnosis of liver cirrhosis using DNA-sequenced-based total serum protein glycomics. EASL congress, Berlin 2004. Abstract 206, Journal of Hepatology, vol 40(suppl1) (poster presentation).

R.Troisi, R.Montalti, S.Ricciardi, M.Praet, I.Colle, H.Van Vlierberghe, B.de Hemptinne.

Prolonged postoperative hyperbilirubinemia following adult-to-adult living donor liver

transplantation – a multivariate analysis of associated risk factors influencing

outcome.American Transplant Congress, Boston, USA, American Journal of Transplantation

2004 supplement 8, vol 4, Abstract 84 (poster presentation).



transplantation – a multivariate analysis of associated risk factors influencing outcome. Xth

Annual International Liver Transplantation Society Congress. Kyoto, Japan. June 2004 (oral

presentation).

E.Vranken, B.Lambert, P.Smeets, H.Van Vlierberghe, R.Dierckx, C. Van de Wiele.

Usefullness of FDG PET in intrahepatic and perihilar cholangiocarcinoma. Annual Congress

of the European Association of Nuclear Medicine. Helsinki, Finland, September 4-8, 2004

(poster presentation).



transplantation – a multivariate analysis of associated risk factors influencing outcome.

Liver Transplantation, vol 10, N° 6, 2004 (abstract).

R.Troisi, R.Montalti, S.Ricciardi, I.Colle, H.Van Vlierberghe, B.de Hemptinne. Biliary

complications in adult-to-adult living donor liver transplantations: really a matter of

learning curve? Liver Transplantation, vol 10, N° 6, 2004 (abstract).

P.Smeets, R.Troisi, L.Delrue, C.Schelstraete, S.Ricciardi, H.Van Vlierberghe, I.Colle, B.de

Hemptinne. Value of multidetector computed tomographic cholangio-graphy (MDCT-CA) in

the preoperative assessment of biliary anatomy in living donor liver surgery: a radiological-

surgical comparison. Liver Transplantation, vol 10, N° 6, 2004 (abstract).

A. Geerts, I. Colle, A. De Vriese, S. Mortier, H. Van Vlierberghe, N. Lameire, M. De Vos.

Increased angiogenesis and permeability in the peritoneal microcirculation of rats with

cirrhosis and portal hypertension. 105th Digestive Disease Week and American

Gastroenterological Association. New Orleans, 15-20 May 2004. Gastroenterology 2004;

Suppl 2; 126: abstract 321 page A 680 (oral presentation).


Prolonged postoperative hyperbilirubinemia following adult-to-adult living donor

transplantation: a multivariate analysis of risk factors. ESOT meeting 5-10 September

2004, Vienna.

Transplantation, vol 78, nr 2, 2004: Ab O366 (poster presentation).

R.Troisi, , R.Montalti, S.Ricciardi, I.Colle, H.Van Vlierberghe, B.de Hemptinne. Biliary

complications in adult-to-adult living donor liver transplantations: really a matter of

learning curve? ESOT meeting 5-10 September 2004, Vienna.

Transplantation, vol 78, nr 2, 2004: Ab O455 (poster presentation).

R.Troisi, P.Smeets, L.Delrue, S.Ricciardi, H.Van Vlierberghe, I.Colle, B.de Hemptinne.

Value of multidetector computed cholangiography (MDCT-CA) in the preoperative

assessment of biliary anatomy in living donor liver surgery: a radiological-surgical

comparison. ESOT meeting 5-10 September 2004, Vienna.

Transplantation, vol 78, nr 2, 2004: Ab P476 (poster presentation).

R.Troisi, H.Van Vlierberghe, S.Ricciardi, P.Smeets, M.Praet, I.Colle, B.de Hemptinne.

Cadaveric or living donor liver transplantation for hepatocellular carcinoma: is the

extension of the Milan criteria deleterious for tumor-free survival? . ESOT meeting 5-10

September 2004, Vienna.

Transplantation, vol 78, nr 2, 2004: Ab P574 (poster presentation).

A.Geerts, I.Colle, H.Van Vlierberghe, A. De Vriese, E.Vanheule, S.Mortier, N.Lameire,

M.De Vos. The influence of peginterferon-alpha therapy on the decreased leukocyte

recruitment in the peritoneal microcirculation of rats with portal hypertension and

cirrhosis. UEGW meeting , October 2004,Prague.

Gut vol 36, Suppl nr. 1, 2004, WED-G-141 (poster presentation).

I.Colle, A.Geerts, A.De Vriese, H.Van Vlierberghe, N.Lameire, M.De Vos. In vivo vascular

hyporeactivity in the mesenteric artery of rats with cirrhosis: reversed by octreotide.

UEGW meeting , October 2004,Prague.

Gut vol 36, Suppl nr. 1, 2004, WED-G-125 (poster presentation).

I.Colle, L.De Schrijver, D.Dooremont, H.Van Vlierberghe, M.De Vos, L.Defreyne.

Transjugular intrahepatic portosystemic shunt: predictive factors for patient survival and

shunt occlusion. UEGW meeting , October 2004,Prague.

Gut vol 36, Suppl nr. 1, 2004, MON-G-75 (poster presentation).

F.Nevens, T.Roskams, H.Van Vlierberghe, Y.Horsmans, D.Sprengers, A.Elewaut,

V.Desmet, L.Libbrecht, G.Leroux-Roels, A. De Brauwer, E. Depla, S.Dincq, C. Vander

Stichele, F.Hulstaert, G.Maertens. Improvement in liver histology after 3 years of E1

therapeutic vaccination in 23 patients with chronic hepatitis C. AASLD meeting,

November 2004, Boston.

Hepatology, Vol 40, Nr 4 suppl 1, Ab194, 2004 (oral presentation).

I.Desombere, H.Van Vlierberghe, S.Couvent, F.Clinckspoor, G.Leroux-Roels. Comparison

of two qualitative and two quantitative assays for HCV RNA detection and quantification:

impact on diagnosis and treatment of HCV infections. . AASLD meeting, November 2004,

Boston.

Hepatology, Vol 40, Nr 4 suppl 1, Ab1188, 2004 (poster presentation).

R.Troisi, V.Donckier, S.Ricciardi, I.Colle, H.Van Vlierberghe, M.Toungouz, L.Noens, A. Le

Moine, M.Goldman, B.de Hemptinne. Immunosuppression withdrawal after

myeloconditioning and donor stem cells infusions in living donor transplantation: a pilot

study. Third International Congress on Immunosupression. San Diego, December 2004

(oral presentation).

A.Geerts, I. Colle, H. Van Vlierberghe, A. De Vriese, E. Vanheule, S. Mortier, N. Lameire,

M. De Vos, I. Colle. Influence of peginterferon-alpha therapy on the decreased leukocyte

recruitment in the peritoneal microcirculation of rats with portal hypertension and

cirrhosis. Belgian Week of Gastroenterology, 24th February 2005, Spa, Belgium. Acta

Gastroenterologica Belgica 2005; 68 Abstract A10 (oral presentation).

C.George, F.D'Heygere, F.Nevens, H.Van Vlierberghe, O.Van Der Meeren. Patients

infected with HCV-5 present the same response rate than patients infected with HCV-1:

results form the Belgian randomised trial for naive and relapsers ( Bernar-1). Belgian

Week of Gastroenterology, 24th February 2005, Spa, Belgium. Acta Gastroenterologica

Belgica 2005; 68 Abstract A12 (oral presentation).

E. Vanheule, AM. Geerts, H. Van Vlierberghe, M. De Vos, I. Colle. An experimental animal

model of micronodular cirrhosis induced by subcutaneous administration of carbon

tetrachloride in mice. Belgian Week of Gastroenterology, 24th February 2005, Spa,

Belgium. Acta Gastroenterologica Belgica 2005; 68 Abstract A20.

P.Michielsen, E.Bottieau, H.Van Vlierberghe and the BASL. Treatment of chronic hepatitis

C in patients co-infected with HIV with weekly peginterferon and ribavirin. Belgian Week

of Gastroenterology, 24th February 2005, Spa, Belgium. Acta Gastroenterologica Belgica

2005; 68 Abstract A24 (oral presentation).

F.Nevens, H.Van Vlierberghe, F.D'Heygere, J.Delwaide, M.Adler, J.Henrion, J.Henry,

A.Hendlisz, P.Michielsen, B.Bastens, R.Brenard, O.Van Der Meeren. Peginterferon alfa-2a

(40 kd) plus ribavirin is as effective in patients relapsing after conventional interferon

based therapy than in naive patients: results from the Bernar-1 trial. Belgian Week of

Gastroenterology, 24th February 2005, Spa, Belgium. Acta Gastroenterologica Belgica

2005; 68 Abstract A27 en D09 (oral presentation).

M. Adler, B. Bastens, I. Colle, J. Delwaide, J. Henrion, Y. Horsmans, P.Michielsen, JP.

Mulkay, P. Yap, H. Van Vlierberghe. Treating Belgian naive chronic hepatitis C patients

with peginterferon alpha 2b and ribavirin in real life (the pegintrust study). Belgian Week

of Gastroenterology, 24th February 2005, Spa, Belgium. Acta Gastroenterologica Belgica

2005; 68 Abstract A28.

M. Adler, B. Bastens, I. Colle, J. Delwaide, J. Henrion, Y. Horsmans, P.Michielsen, JP.

Mulkay, P. Yap, H. Van Vlierberghe. Three months data from the pegintrust study:

pegintron in combination with rebetol in real life in Belgium. Belgian Week of

Gastroenterology, 24th February 2005, Spa, Belgium. Acta Gastroenterologica Belgica

2005; 68 Abstract A34 and D61.

V. Donckier, R. Troisi, S. Ricciardi, I. Colle, H. Van Vlierberghe, M. Toungouz, L. Noens,

A. LeMoine, M. Libin, B. de Hemptinne, M. Goldman. Induction of tolerance by

myeloconditioning and donor stem cells infusion in living donor transplantation: a pilot

study. Belgian Week of Gastroenterology, 24th February 2005, Spa, Belgium. Acta

Gastroenterologica Belgica 2005; 68 Abstract D 06 (oral presentation).

I. Colle, A.M. Geerts, E. Vanheule, H. Van Vlierberghe, A. De Vriese, N. Lameire, J. Van

De Voorde, M. De Vos. Mesenteric artery hyporeactivity of cirrhotic rats is not restored

after acute administration of octreotide or somatostatine. Acta Gastroenterologica

Belgica 2005; 68: Abstract A09. Belgian Week of Gastroenterology, Spa, 24th of Februari

2005 (oral presentation).

I.Colle, A.Geerts, A.De Vriese, H.Van Vlierberghe, N.Lameire, J.Van De Voorde, M.De

Vos. In vivo vascular hyporeactivity in the mesenteric artery of rats with cirrhosis:

reversed by chronic octreotide LAR administration. EASL meeting, Paris, April 2005.

J Hepatol, vol 42, suppl 2, Ab 158, 2005 (poster presentation).

F.D’Heygere, C.George, F.Nevens, H.Van Vlierberghe, O.Van Der Meeren. Patients

infected with HCV-5 present the same response rate as patients infected with HCV-1:

results from the Belgian randomised trial for naïve and relapsers ( BERNAR-1).

EASL meeting, Paris, April 2005.


F.Nevens, H.Van Vlierberghe, F.D’Heygere, J.Delwaide, M.Adler, J.Henrion, J.P.Henry,

A.Hendlisz, P.Michielsen, B.Bastens, R.Brenard, O.Van Der Meeren. Peginterferon alfa-

2a(40 kDa) plus ribavirine is as effective in patients relapsing after conventional

interferon based treatment as in naïve patients: results form the Bernar-1 trial.

EASL meeting, Paris, April 2005.


V.Hutse, E.Verhaegen, L.De Cock, S.Quolin, H.Vandenberghe, Y.Horsmans, P.Michielsen,

P.Van Damme, H.Van Vlierberghe, F.Claeys, R.Vranckx, H.Van Oyen. Oral fluid as a

medium for the detection of hepatitis B surface antigen.

World congress of Pathology and Laboratory Medicine, Istanbul, May 2005 (poster

presentation).

A.M.Geerts, K.Cheung, E.Vanheule, H.Van Vlierberghe, M.De Vos, I.Colle. Expression of

ICAM-1 in the peritoneal microvessels of rats with portal hypertension and cirrhosis

treated with and without interferon remains decreased.

World Congress of Gastroenterology 2005. September 10-14, 2005. Montréal, Canada.

Abstract R990 (poster presentation).

AM Geerts, KJ Cheung, E. Vanheule, H. Van Vlierberghe, M. De Vos, I. Colle. Expression

of E-selectin, P-selectin and ICAM-1 in the peritoneal microvessels of portal hypertensive

and cirrhotic rats treated with or without peginterferon-alpha2a. Vlaamse Vereniging

Voor Gastroenterologie (VVGE-NVGE) 7 Oktober 2005, Velthoven, Nederland (oral

presentation)

A.M.Geerts, K.Cheung, E.Vanheule, H.Van Vlierberghe, M.De Vos, I.Colle. Expression of

ICAM-1 in the peritoneal micro vessels of rats with portal hypertension and cirrhosis

treated with and without interferon remains decreased.

World Congress of Gastroenterology 2005. September 10-14, 2005. Montréal, Canada.

Abstract R990 (poster presentation).

KJ Cheung, A.M Geerts, E. Vanheule, H. Van Vlierberghe, M. De Vos, I. Colle. Expression

of E-selectin, P-selectin and ICAM-1 in the peritoneal microvessels of portal hypertensive

and cirrhotic rats treated with or without peginterferon-alpha2a. Gut 2005; 54 (suppl

VII) A 40, OP-G-177, UEGW Kopenhagen, Denemarken.(oral presentation)

E. Vanheule, AM Geerts, H. Reynaert, H. Van Vlierberghe, A. Geerts, M. De Vos, I. Colle.

Intravital microscopy study of the influence of somatostatin on liver microcirculation in

an experimental mouse model of cirrhosis. Gut 2005; 54 (suppl VII) A41, OP-G-178,

UEGW Kopenhagen, Denemarken. (oral presentation)

E. Vanheule, AM Geerts, H. Van Vlierberghe, M. De Vos, I. Colle. An experimental model

of micronodular cirrhosis induced by subcutaneous administration of carbon tetrachloride

in mice. Gut 2005; 54 (suppl VII) A191, TUE-G-188 UEGW, Kopenhagen, Denemarken.

(poster presentation).

H.Van Vlierberghe. The detection and treatment of hepatocellular carcinoma. Single topic

symposium, Erasmus Liver Day, Rotterdam, The Netherlands. 30-11-2005 (invited

lecture).

AM Geerts, S. Bergiers, E. Vanheule, H. Van Vlierberghe, M. De Vos, I. Colle. Increased

neo-angiogenesis and vascular endothelial growth factor (VEGF) protein expression in

the lung of cirrhotic mice. Acta Gastroenterologica Belgica 2006; 69: Abstract A05 (oral

presentation)

AM Geerts, E. Vanheule, P. Carmeliet, H. Van Vlierberghe, L. Leybaert, M. De Vos, I.

Colle. Role of placental growth factor in the mesenteric neo-angiogenesis of portal

hypertensive mice. Acta Gastroenterologica Belgica 2006; 69: Abstract A15 (oral

presentation)

AM Geerts, E. Vanheule, H. Van Vlierberghe, M. De Vos, I. Colle. Rapamycin prevents

mesenteric neo-angiogenesis in portal hypertensive mice. Acta Gastroenterologica

Belgica 2006; 69: Abstract A16 (oral presentation)

E. Vanheule, AM Geerts, H. Vanvlierberghe, M. Praet, M. De Vos, I. Colle. Mice models of

portal hypertension and cirrhosis. Acta Gastroenterologica Belgica 2006; 69: Abstract

A22 (poster presentation)

E. Vanhuele, AM Geerts, H. Reynaert, H. Van Vlierberghe, A. Geerts, M. De Vos, I. Colle.

Influence of somatostatin and octreotide on liver microcirculation in an experimental

mouse model of cirrhosis studied by intravital fluorescence microscopy. Acta

Gastroenterologica Belgica 2006; 69: Abstract A11 (oral presentation)

KJ Cheung, A.M Geerts, E. Vanheule, H. Van Vlierberghe, M. De Vos, I. Colle. The

expression of E-selectin, P-selectin and ICAM-1 in the peritoneal microvessels of portal

hypertensive and cirrhotic rats treated with or without peginterferon-alpha2a. Acta

Gastroenterologica Belgica 2006; 69: Abstract A13 (oral presentation)

M.Sainz-Barriga, R.Troisi, G.Carbotta, A.Cesana, S.Ricciardi, H.Van Vlierberghe, I.Colle,

B.de Hemptinne. Split liver transplantation with extended right grafts. Single center

matched pairs outcome analysis. Belgian Transplantation Society Annual meeting,

Brussels, 21 april 2006.

M.Sainz-Barriga, S.Ricciardi, H.Van Vlierberghe, I.Colle, G.Carbotta, A.Cesana,

F.Berrevoet, S.De Gendt, B.de Hemptinne, R.Troisi. Late liver retransplantation with

living donors: a case-control outcome analysis. Belgian Transplantation Society Annual

meeting, Brussels, 21 april 2006.

M. Adler, J. Lerut, P. Starkel, H. Van Vlierberghe, R. Troisi, F. De Pauw, A. Fancello, G.

Bonduel, E. De Gendt, P. Vereerstraeten, V. Donckier, O. Detry, J. Delwaide, P.

Michielsen, T. Chapelle, J. Pirenne, F. Nevens Outcome of patients with hepatocellular

carcinoma listed for liver transplantation within the Eurotransplant allocation system.

EASL conference Vienna, 26 april 2006 (oral presentatation).

H. Wedemeyer, H. Van Vlierberghe, H. Blum, F. Nevens, M. Gschwantler, S. Zeuzem, T.

Roskams, V. Desmet, S. Dincq, C. Vander Stichele, H. De Winter, G. Maertens, Y.

Horsmans and the T2S-916-HCV study group. E1 therapeutic vaccination in patients

with chronic HCV genotype 1 infection: results of a 15-month, placebo-controlled trial.

EASL conference Vienna, april 2006 (poster presentation).

A.M. Geerts , E. Vanheule , H. Van Vlierberghe , M. De Vos , I. Colle. Rapamycin prevents

mesenteric neo-angiogenesis in portal hypertensive mice. EASL conference Vienna, april

2006 (poster presentation).

A.M. Geerts , S. Bergiers , E. Vanheule , H. Van Vlierberghe , M. De Vos , I. Colle.

Increased neo-angiogenesis and vascular endothelial growth factor (VEGF) expression in

the lung of cirrhotic mice. EASL conference Vienna, april 2006 (poster presentation).

E. Vanheule , A.M. Geerts , H. Reynaert , H. Van Vlierberghe , A. Geerts, M. De Vos, I.

Colle. Influence of somatostatin and octreotide on liver microcirculation in an

experimental mouse model of cirrhosis studied by intravital microscopy. EASL conference

Vienna, april 2006 (poster presentation).

A.M.Geerts, E.Vanheule, P.Carmeliet, H.Van Vlierberghe, L.Leybaert, M.De Vos, I.Colle.

Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal

hypertensive mice. AASLD conference October 2006, Boston, USA (oral presentation).

A.M.Geert, E.Vanheule, H.Van Vlierberghe, M.De Vos, I.Colle. Rapamycin reduces

splanchnic blood flow by inhibiting neo-angiogenesis in portal hypertensive mice. AASLD

conference October 2006, Boston, USA (poster presentation).

Isabelle Desombere, Hans Van Vlierberghe, Sibyl Couvent, Filip Clinckspoor, and Geert

Leroux-Roels. Comparison of two qualitative and two quantitative assays for HCV-RNA

detection and quantification : impact on diagnosis and treatment of HCV infections.

AASLD conference October 2006, Boston, USA (poster presentation).

A.Geerts, E. Vanheule, P. Carmeliet, H. Van Vlierberghe, L. Leybaert, M. De Vos, I.

Colle. Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal

hypertensive mice. Acta Clinica Belgica 2006: 61, page 298 (oral presentation)

Belgische Vereniging voor Inwendige Geneeskunde.

E. Vanheule, AM Geerts, M. Praet, H. Van Vlierberghe, M. De Vos, I. Colle. Development

of portal hypertension and cirrhosis after CCL4 and CBDL in mice models: a histological

and ultrastructural approach. Acta Clinica Belgica 2006; 61, page 310 (poster

presentation) Belgische Vereniging voor Inwendige Geneeskunde.

R. Troisi, P. Smeets, J. van Huysse, I. Colle, H. Van Vlierberghe, B. de Hemptinne. The

value of laparoscopic liver surgery for benign hepatic tumors. XIXth Belgian Week of

Gastroenterology. 8-10th February 2007, Oostende. Acta Gastroenterologica Belgica

2007; 70: Abstract D06.

M. Adler, B. Bastens, I. Colle, J. Delwaide, J. Henrion, Y. Horsmans, P. Michielsen, P.

Golstein, JP Mulkay, F. Nevens, W. Van Steenbergen, AM Denys, JP Brasseur, H. Van

Vlierberghe. Effectiveness and tolerability of Pegintron Ò in combination with Rebetol Ò

in real life: the Pegintrust study. XIXth Belgian Week of Gastroenterology. 8-10th

February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract D51.

R. Troisi, C. Breusegem, F. Berrevoet, J. Van Huysse, M. Praet, I. Colle, H. Van

Vlierberghe, B. de Hemptinne. Evidence of prolonged overall survival using rapamycin as

main immunosuppression in patients transplanted for primary hepatocellular carcinoma

with extended criteria on pathology. XIXth Belgian Week of Gastroenterology. 8-10th

February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract P19.

K. Cheung, D. Deforce, K. Tilleman, I. Colle, H. Van Vlierberghe. Serum proteomics profiling in HCV patients with liver fibrosis. XIXth Belgian Week of Gastroenterology. 8-10th February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract A17. E. Vanheule, AM Geerts, M. Praet, C. Van Steenkiste, H. Van Vlierberghe, M. De Vos, I. Colle. Intravital microscopy study of the development of cirrhosis in CBDL and CCl4 mice models. XIXth Belgian Week of Gastroenterology. 8-10th February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract A23.

AM Geerts, E. Vanheule, C. Van Steenkiste, H. Van Vlierberghe, M. De Vos, I. Colle. Development of cirrhosis is associated with increased angiogenesis in the liver. XIXth Belgian Week of Gastroenterology. 8-10th February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract A27.

I. Colle, A. Geerts, E. Vanheule, H. Reynaert, H. Van Vlierberghe, A. Geerts, M. De Vos. Influence of long term and 7d octreotide administartion on somatostatin receptor mRNA expression in aorta abdominalis and mesenteric artery. XIXth Belgian Week of Gastroenterology. 8-10th February 2007, Oostende. Acta Gastroenterologica Belgica 2007; 70: Abstract A22.

R. Troisi, F. Dondero, R. Montalti, F. Durand, I. Colle, H. Van Vlierberghe, J. Belghiti, B. de Hemptinne. Persistent posttransplant hyperbilirubinemia (> 10 days/> 10mg/dl) correlates with low graft and patient survival following adult to adult living donor liver transplantation. A multivariate analysis of 143 consecutive patients from the Ghent-Beaujon series. American Transplant Congress, San Francisco 5-9 May 2007. American Journal of Transplantation 2007;suppl 2: 214; Abstract 259 (oral presentation)

M. Sainz-Barriga, S. Ricciardi, I. Colle, H. Van Vlierberghe, P.Conoscitore, B. de Hemptinne, R. Troisi. Prediction of survival after late liver retransplantation with deceased and living donor liver grafts : a comparative analysis on preoperative prognostic scores. American Transplant Congress, San Francisco 5-9 May 2007. American Journal of Transplantation 2007; suppl 2: 379; Abstract 898 (poster presentation).

M. Sainz-Barriga, C. Breusegem, S. Ricciardi, J. Van Huysse, I. Colle, H.Van Vlierberghe, P. Conoscitore, B. de Hemptinne, R. Troisi. Evidence of prolonged overall survival using rapamycin as main immunosuppression in patients transplanted for primary hepatocellular carcinoma with extended criteria on pathology. American Transplant Congress, San Francisco 5-9 May 2007. American Journal of Transplantation 2007; suppl 2: 468; Abstract 1250(poster presentation).

H. Van Vlierberghe.

Ulcus bulbi en ventriculi : een infectieziekte ?

Echologienummer september 1995.

H. Van Vlierberghe.

Achalasie : van walvisbeen tot botulinetoxine.

Echologienummer november 1995.

VARIA

- Winner of the yearly price of the Vlaamse gastro-enterologische vereniging 1994

1995: 'LKM1, betekenis postlevertransplantatie ?'

- Winner of the yearly price of the Vlaamse gastro-enterologische vereniging 1998-

1999, met het onderwerp: 'Invloed van het hemochromatosegen Cys282Tyr en het

haptoglobine phenotype op het ijzermetabolisme bij patiënten met chronische hepatitis

C.'

- Forming in hepatology November-December 1995 in The Royal Free Hospital London,

United Kingdom (Prof. Dr. N. McIntyre).

- Member of the Hepatitis Advisory Board (HAB), Belgium.

- Secretary of the Belgische Vereniging voor Endoscopie van het Spijsverteringsstelsel

(B.V.E.S./S.B.E.D.). 1997 – 2002.

- Member of the steering board of the BASL ( Belgian Association for the Study of the

Liver).

- Member of the Belgian Intestinal Transplantation Committee.

- Freelance docent Mercator Hoge School voor Verpleegkunde, Gent. Academiejaar 1996-

1997. Course : Upper GI endoscopy.

- Founding member of the BASL (Belgian Association of the Study of the Liver).

- Principal investigator BASL 97-53 trial : Multicenter trial (Benelux) comparing standard

interferon and ribavirine versus induction interferon treatment and ribavirine in patients

with chronic hepatitis C.

• Reviewer van 'Gastroenterology, Official Journal of the American

Gastroenterological Association' Jaargang 1997.

• Reviewer van 'Acta Gastro-Enterologica Belgica' Jaargang 1997- 2001.

• Reviewer van Acta Clinica Belgica. Jaargang 2000, 2001, 2005 en 2007.

• Reviewer van Tijdschrift voor Geneeskunde, jaargang 2002, 2004, 2005.

• Reviewer van ‘Clinical Chemistry’, jaargang 2003 en 2004, 2005.

• Reviewer van ‘Clinica Chimica Acta’, jaargang 2006.

• Reviewer van ‘Liver International’, jaargang 2003, 2004 en 2006.

• Reviewer van ‘Journal of Hepatology’, jaargang 2004.

• Reviewer van ‘Seizure, European Journal of Epilepsy’, jaargang 2005.

• Reviewer van ‘Acta Neurologica Belgica’, jaargang 2005.

• Reviewer van ‘The Cochrane Hepatobiliary Group Module in The Cochrane

Library’, 2005.

• Reviewer van ‘Nephrology, Dialysis and Transplantation’, jaargang 2005.

• Reviewer van ‘Alimentory Pharmacology Therapeutics’, jaargang 2006

MEMBERSHIPS

- Secretary of The Belgian Liver and Intestinal transplantation Committee - Member of the Belgian Transplantation Society - Member of the Belgian Transplantation Council - Member of the Eurotransplant Liver and Intestinal Audit Committee

(Eurotransplant).

CURRICULUM VITAE Name : VAN...

Documents

Transcript of CURRICULUM VITAE Name : VAN...